BioCentury
ARTICLE | Politics, Policy & Law

Readout for Gilead’s remdesivir in COVID-19 could warrant emergency use authorization

BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.

April 29, 2020 2:12 PM UTC
Updated on May 1, 2020 at 9:21 PM UTC


Access this Article

BCIQ Company Profiles

Gilead Sciences Inc.